News

Announcement – CSO Appointment

We are excited to announce that Minttu Kansikas has been appointed as Chief Scientific Officer to lead the research efforts and laboratory functions. Congratulations! Minttu is a co-inventor and one of the leading scientists behind

... read more
19.12.2019

Welcome to our updated Website

Welcome! We have updated our website and hope you enjoy the new structure and features! This new section being one of them, and the twitter feed, being another. And there are many more to come!

... read more
18.12.2019

LS CancerDiag joins InvestHorizon Accelerator

LS CancerDiag joins the InvestHorizon Accelerator, we are delighted to have been accepted to the programme! InvestHorizon is an accelerator programme designed to facilitate the access to Series A funding. The selected deep tech companies

... read more
18.10.2019

LS CancerDiagFollow

Avatar
Retweet on TwitterLS CancerDiag Retweeted
AvatarULISES@ulises_eu·
11 Jan

📢 One of the missions that the @EU_Commission is launching, is the #MissionCancer which aims to save three million more lives in the next ten years.

🩺 The first priority is to understand cancer and the second priority is prevention

Read more 👉 https://www.euronews.com/2020/11/09/europe-s-mission-against-cancer-working-to-improve-patient-care

Reply on Twitter 1348572263331864576Retweet on Twitter 13485722633318645762Like on Twitter 13485722633318645763Twitter 1348572263331864576
AvatarLS CancerDiag@lscancerdiag·
23 Dec

As this peculiar year comes to an end, we hope that you will make time to wind down and spend time with your loved ones, be it in a small safe circle or in whichever conditions your location may allow.

We wish you happy holidays and look forward to seeing you in a better 2021!

Reply on Twitter 1341789830225772552Retweet on Twitter 1341789830225772552Like on Twitter 13417898302257725522Twitter 1341789830225772552
AvatarLS CancerDiag@lscancerdiag·
21 Dec

In such a difficult year it's even more important to highlight and celebrate achievements! To start the week positively, let's put our hands together for our newly appointed Production Manager: Mariann Kasela. Congratulations! #promotion #WomenInSTEM #PhD https://www.linkedin.com/feed/update/urn:li:activity:6746743826234273793

Reply on Twitter 1340986473999429633Retweet on Twitter 13409864739994296331Like on Twitter 13409864739994296331Twitter 1340986473999429633
AvatarLS CancerDiag@lscancerdiag·
13 Dec

We are very sad to hear the news of Albert's passing, our hearts go out to his family. He was a truly remarkable scientist and inspiration to all of us. https://news.osu.edu/ohio-state-announces-passing-of-longtime-cancer-genetics-researcher-albert-de-la-chapelle/

Reply on Twitter 1338110579551170560Retweet on Twitter 1338110579551170560Like on Twitter 13381105795511705602Twitter 1338110579551170560
AvatarLS CancerDiag@lscancerdiag·
11 Dec

The weekend is near, but before you close your laptop, have a look at our new neat video. We hope you like it as much as we do! Let us know what you think! #LynchSyndrome #DiagMMR #CancerPrevention #MissionCancer
https://www.lscancerdiag.com/diagmmr-lynch-syndrome-video/

Reply on Twitter 1337414146493657091Retweet on Twitter 13374141464936570913Like on Twitter 133741414649365709111Twitter 1337414146493657091
Load More...

Contact Us

  • For general inquiries:
    contact (at) lscancerdiag.com
  • For technical support:
    +358 40 6602622
  • LS CancerDiag Ltd
    c/o Terkko Health Hub
    Haartmaninkatu 4, Building 14
    00290 Helsinki
    Finland

Privay Policy

Privacy Statement

This document informs you about privacy issues such as the collection, storage, use and disclosure of personal information received from users of this Website, and of personal information received in the course of the provided services.

The LS CancerDiag Ltd is controller of your personal data, which it collects from its website visitors. This means that LS CancerDiag:

  1. collects your data on a legal basis and decides the purpose of this data.

 

Related to its services, LS CancerDiag is processor of your personal data, which it receives from the controller, for example, your hospital. Regarding this data, LS CancerDiag is processor of your data, which means that we:

  1. act on behalf of the controller.
Contact

If you have any questions about this Privacy Policy, your data, or if you would like to exercise one of your data protection rights, please do not hesitate to contact our data protection officer at:

LS CancerDiag Ltd
Business ID 2558287-9
c/o Terkko Health Hub
Haartmaninkatu 4, Building 14
00290 Helsinki
Finland

Email: dpo@europeanstartuplawyer.com

Data Collection

From our website visitors, we collect data such as:

  • Name
  • Email
  • Cookies

 

We collect this data based on your consent, Article 6 (1) (a) of the European General Data Protection Regulation 2016/679, because you like to stay updated on our newsletters, marketing offers, or you have reached out to us for information or questions.

Regarding our services LS CancerDiag collects data such as:

  • Patient name and / or reference
  • Skin samples to be analyzed for Lynch syndrome
  • Family reference numbers related to Lynch syndrome

 

This data is collected to fulfill on the contractual obligation, pursuant Article 6 (1) (b) of the European General Data Protection Regulation 2016/679.

Since LS CancerDiag is collecting special category data, such as genetic data and health-related data, we have ensured additional organizational measures, such as an appointed data protection officer, and implemented technical measures to secure the data and ensure safe processing.

Research data

We use health-related and genetic data, we receive according to contractual obligations, in encrypted form to research and improve analysis and diagnoses related to Lynch syndrome.

Analytical data

Analytical data is anonymously collected and therefore not subjected to the GDPR.

Storing Data

The Company stores your data in secure locations, such as the password protected and authorization-accessible database of the host domain of the Company.

Retention

With regards to European data protection legislation and Finnish taxation laws, we will store your data that is necessary for tax-related purposes for a minimum of 6 years.

Data related to your health, and results from the research projects, will be stored for as long as the project aim last.

Once your personal data is removed based on one of the reasons as stated above, it cannot be retrieved unless you or the contractual provider sends it again to us for reasons as stated previously in this policy.

Transfer

We do not internationally transfer your data outside the Union, or share it to Third Parties for marketing purposes.

Automated individual decision-making

We do not use any automated individual decision-making tools.

Your Rights

You, a website visitor, customer or other party, have at all times the right to:

  1. access your data and request copies of all processing activities concerning your data;
  2. rectify information concerning any data about you that you believe is inaccurate;
  3. request to be forgotten, to which the Company under certain conditions cannot comply, such as when it is following a legal obligation from a National Authority, or reasons for public interest or public health;
  4. request to restrict or object to processing, to which the Company under certain conditions cannot comply, such as when it is following a legal obligation from a National Authority, or reasons for public interest or public health;
  5. request a structured, commonly used and machine-readable format to transfer the data to another controller or directly to you (portability).
Changes to the Policy

This policy was last updated December 2020. LS CancerDiag Ltd will keep this privacy policy continuously under review and reserves the right to modify this document. LS CancerDiag Ltd

advises you to regularly consult this document for the latest updates.

Should you wish to report a complaint or you feel LS CancerDiag Ltd has not addressed your concerns in a satisfying manner, you may contact the Data Protection Authority in Finland or in your country of residence.

Privacy Policy

Navigate

Follow us

Linkedin
Twitter
Facebook
Youtube
Follow LS CancerDiag on F6S

Send message

Newsletter Subscription

X-Europe
bf_logo_blue_rgb
image (2)
ProHEALTH_accelerator_colour
EIT Health accelerated by - Web
StartupHealth
Previous
Next
X-Europe